These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

326 related items for PubMed ID: 11423566

  • 1. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis.
    Lema GP, Maier H, Nieto E, Vielhauer V, Luckow B, Mampaso F, Schlöndorff D.
    J Am Soc Nephrol; 2001 Jul; 12(7):1369-1382. PubMed ID: 11423566
    [Abstract] [Full Text] [Related]

  • 2. Late onset of treatment with a chemokine receptor CCR1 antagonist prevents progression of lupus nephritis in MRL-Fas(lpr) mice.
    Anders HJ, Belemezova E, Eis V, Segerer S, Vielhauer V, Perez de Lema G, Kretzler M, Cohen CD, Frink M, Horuk R, Hudkins KL, Alpers CE, Mampaso F, Schlöndorff D.
    J Am Soc Nephrol; 2004 Jun; 15(6):1504-13. PubMed ID: 15153561
    [Abstract] [Full Text] [Related]

  • 3. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G, Maier H, Franz TJ, Escribese M, Chilla S, Segerer S, Camarasa N, Schmid H, Banas B, Kalaydjiev S, Busch DH, Pfeffer K, Mampaso F, Schlöndorff D, Luckow B.
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [Abstract] [Full Text] [Related]

  • 4. Enhanced osteopontin expression and macrophage infiltration in MRL-Fas(lpr) mice with lupus nephritis.
    Wüthrich RP, Fan X, Ritthaler T, Sibalic V, Yu DJ, Loffing J, Kaissling B.
    Autoimmunity; 1998 Dec; 28(3):139-50. PubMed ID: 9867126
    [Abstract] [Full Text] [Related]

  • 5. Chemokine and chemokine receptor expression during initiation and resolution of immune complex glomerulonephritis.
    Anders HJ, Vielhauer V, Kretzler M, Cohen CD, Segerer S, Luckow B, Weller L, Gröne HJ, Schlöndorff D.
    J Am Soc Nephrol; 2001 May; 12(5):919-931. PubMed ID: 11316850
    [Abstract] [Full Text] [Related]

  • 6. Transcription factor Fli-1 impacts the expression of CXCL13 and regulates immune cell infiltration into the kidney in MRL/lpr mouse.
    Sato S, Zhang XK, Matsuoka N, Sumichika Y, Saito K, Yoshida S, Matsumoto H, Temmoku J, Fujita Y, Asano T, Migita K.
    Lupus Sci Med; 2023 Apr; 10(1):. PubMed ID: 37094946
    [Abstract] [Full Text] [Related]

  • 7. Protective role for CCR5 in murine lupus nephritis.
    Turner JE, Paust HJ, Bennstein SB, Bramke P, Krebs C, Steinmetz OM, Velden J, Haag F, Stahl RA, Panzer U.
    Am J Physiol Renal Physiol; 2012 Jun 01; 302(11):F1503-15. PubMed ID: 22442210
    [Abstract] [Full Text] [Related]

  • 8. The Friend leukaemia virus integration 1 (Fli-1) transcription factor affects lupus nephritis development by regulating inflammatory cell infiltration into the kidney.
    Sato S, Zhang XK.
    Clin Exp Immunol; 2014 Jul 01; 177(1):102-9. PubMed ID: 24580413
    [Abstract] [Full Text] [Related]

  • 9. (5R)-5-hydroxytriptolide ameliorates lupus nephritis in MRL/lpr mice by preventing infiltration of immune cells.
    Zhang LY, Li H, Wu YW, Cheng L, Yan YX, Yang XQ, Zhu FH, He SJ, Tang W, Zuo JP.
    Am J Physiol Renal Physiol; 2017 Apr 01; 312(4):F769-F777. PubMed ID: 28100505
    [Abstract] [Full Text] [Related]

  • 10. Antagonist of monocyte chemoattractant protein 1 ameliorates the initiation and progression of lupus nephritis and renal vasculitis in MRL/lpr mice.
    Hasegawa H, Kohno M, Sasaki M, Inoue A, Ito MR, Terada M, Hieshima K, Maruyama H, Miyazaki J, Yoshie O, Nose M, Fujita S.
    Arthritis Rheum; 2003 Sep 01; 48(9):2555-66. PubMed ID: 13130475
    [Abstract] [Full Text] [Related]

  • 11. Involvement of infiltrating macrophage-derived activin A in the progression of renal damage in MRL-lpr mice.
    Kadiombo AT, Maeshima A, Kayakabe K, Ikeuchi H, Sakairi T, Kaneko Y, Hiromura K, Nojima Y.
    Am J Physiol Renal Physiol; 2017 Feb 01; 312(2):F297-F304. PubMed ID: 27881396
    [Abstract] [Full Text] [Related]

  • 12. Retinoic acid treatment protects MRL/lpr lupus mice from the development of glomerular disease.
    Pérez de Lema G, Lucio-Cazaña FJ, Molina A, Luckow B, Schmid H, de Wit C, Moreno-Manzano V, Banas B, Mampaso F, Schlöndorff D.
    Kidney Int; 2004 Sep 01; 66(3):1018-28. PubMed ID: 15327395
    [Abstract] [Full Text] [Related]

  • 13. The fungal lactone oxacyclododecindione is a potential new therapeutic substance in the treatment of lupus-associated kidney disease.
    Henke J, Erkel G, Brochhausen C, Kleinert H, Schwarting A, Menke J, Pautz A.
    Kidney Int; 2014 Oct 01; 86(4):780-9. PubMed ID: 24717299
    [Abstract] [Full Text] [Related]

  • 14. Antagonist of fractalkine (CX3CL1) delays the initiation and ameliorates the progression of lupus nephritis in MRL/lpr mice.
    Inoue A, Hasegawa H, Kohno M, Ito MR, Terada M, Imai T, Yoshie O, Nose M, Fujita S.
    Arthritis Rheum; 2005 May 01; 52(5):1522-33. PubMed ID: 15880599
    [Abstract] [Full Text] [Related]

  • 15. Anti-monocyte chemoattractant protein-1 gene therapy attenuates nephritis in MRL/lpr mice.
    Shimizu S, Nakashima H, Masutani K, Inoue Y, Miyake K, Akahoshi M, Tanaka Y, Egashira K, Hirakata H, Otsuka T, Harada M.
    Rheumatology (Oxford); 2004 Sep 01; 43(9):1121-8. PubMed ID: 15213333
    [Abstract] [Full Text] [Related]

  • 16. Anti-macrophage-derived chemokine antibody relieves murine lupus nephritis.
    Liu H, Diao C, Wu C, Xia L, Duan H, Fang F, Ding S, Xiao W.
    Rheumatol Int; 2011 Nov 01; 31(11):1459-64. PubMed ID: 20473504
    [Abstract] [Full Text] [Related]

  • 17. Microthrombotic Renal Vascular Lesions Are Associated to Increased Renal Inflammatory Infiltration in Murine Lupus Nephritis.
    Gonzalo-Gil E, García-Herrero C, Toldos O, Usategui A, Criado G, Pérez-Yagüe S, Barber DF, Pablos JL, Galindo M.
    Front Immunol; 2018 Nov 01; 9():1948. PubMed ID: 30210500
    [Abstract] [Full Text] [Related]

  • 18. CXCR3 mediates renal Th1 and Th17 immune response in murine lupus nephritis.
    Steinmetz OM, Turner JE, Paust HJ, Lindner M, Peters A, Heiss K, Velden J, Hopfer H, Fehr S, Krieger T, Meyer-Schwesinger C, Meyer TN, Helmchen U, Mittrücker HW, Stahl RA, Panzer U.
    J Immunol; 2009 Oct 01; 183(7):4693-704. PubMed ID: 19734217
    [Abstract] [Full Text] [Related]

  • 19. IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-Faslpr Mice.
    Wada Y, Gonzalez-Sanchez HM, Weinmann-Menke J, Iwata Y, Ajay AK, Meineck M, Kelley VR.
    J Am Soc Nephrol; 2019 Feb 01; 30(2):244-259. PubMed ID: 30622154
    [Abstract] [Full Text] [Related]

  • 20. Enhanced MHC class II expression in renal proximal tubules precedes loss of renal function in MRL/lpr mice with lupus nephritis.
    Wuthrich RP, Yui MA, Mazoujian G, Nabavi N, Glimcher LH, Kelley VE.
    Am J Pathol; 1989 Jan 01; 134(1):45-51. PubMed ID: 2492404
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.